Capital Flow Monitor · Sponsors · CIK 2122108

5D Patient Journey, Inc.

156 BEECHMONT DRIVE, NEW ROCHELLE, NY, 10804 · 7343301773

Biotechnology · Corporation· inc. DELAWARE true 2026

Fit score

—

Offering

$6.0M

Sold

$5.5M

% sold

90.7%

Investors

5

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-06-18 D ·current 506(b) $6.0M $5.5M 90.7% 5 EDGAR ↗
2026-03-31 D 506(b) $80 $80 100.0% 4 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Eric Schadt — Executive Officer / Director, New Rochelle, NY
  • Daniel Clark — Executive Officer, New Rochelle, NY
    2 other raises
  • Erick Dai — Executive Officer, New Rochelle, NY

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.